Vimarsana
Biggest News Aggregation in the World

Proceed Notice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Proceed Notice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Proceed Notice Today - Breaking & Trending Today

Cidara Therapeutics : Provides Corporate Update and Reports Third Quarter 2023 Financial Results - Form 8-K -November 02, 2023 at 04:25 pm EDT - Vimarsana News

Cidara Therapeutics : Provides Corporate Update and Reports Third Quarter 2023 Financial Results - Form 8-K -November 02, 2023 at 04:25 pm EDT

Published: November 2, 2023

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results SAN DIEGO, November 2, 2023- Cidara Therapeutics, Inc. , a biotechnology company...

Source: marketscreener.com
Related Topics:
San DiegoUnited StatesNicole DavarpanahVeronica EamesGenentech RocheJeffrey SteinBrian RitchieMundipharma Medical CompanyCidara Therapeutics IncSecurities ExchangeEuropean Medicines AgencyExchange CommissionCenters For Medicare Medicaid ServicesLifesci CommunicationsMelinta TherapeuticsJanssen Pharmaceuticals IncTranslational Research DevelopmentCommittee For Medicinal Products Human UseEuropean CommissionJanssen Pharmaceutical Companies Of JohnsonCidara Therapeutics Provides Corporate UpdateReports Third QuarterMedicinal ProductsHuman UseProceed Notice
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results - Vimarsana News

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Published: November 2, 2023

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing targeted th...

Source: businessinsider.com
Related Topics:
United StatesSan DiegoJeffrey SteinVeronica EamesGenentech RocheBrian RitchieNicole DavarpanahLifesci CommunicationsMelinta TherapeuticsTranslational Research DevelopmentCenters For Medicare Medicaid ServicesExchange CommissionJanssen Pharmaceuticals IncCommittee For Medicinal Products Human UseJanssen Pharmaceutical Companies Of JohnsonEuropean Medicines AgencyEuropean CommissionCidara Therapeutics IncSecurities ExchangeMundipharma Medical CompanyMedicinal ProductsHuman UseProceed NoticeSenior Vice PresidentTranslational Research
Cidara Therapeutics Gains On Election To Proceed Notice For CD388 From Janssen - Vimarsana News

Cidara Therapeutics Gains On Election To Proceed Notice For CD388 From Janssen

Published: September 6, 2023

Cidara Therapeutics, Inc. (CDTX) shares are gaining more than 18 percent on Wednesday morning trade after the company announced that Janssen Pharmaceuticals, Inc.

Source: rttnews.com
Related Topics:
Jeffrey SteinJanssen PharmaCidara Therapeutics IncJanssen Pharmaceuticals IncJanssen Pharmaceutical Companies Of JohnsonCidara TherapeuticsJanssen PharmaceuticalsProceed NoticeJanssen Pharmaceutical CompaniesStock AlertCidara Therapeutics